샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774727

세계의 반려동물 수술후 통증 관리 치료제 시장

Companion Animal Postoperative Pain Management Therapeutics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 474 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 반려동물 수술후 통증 관리 치료제 시장은 2030년까지 3억 620만 달러에 이를 전망

2024년에 1억 8,660만 달러로 추정되는 반려동물 수술후 통증 관리 치료제 세계 시장은 2024-2030년의 분석 기간에 CAGR 8.6%로 성장하여 2030년에는 3억 620만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 비스테로이드성 항염증제는 CAGR 9.6%를 나타내고, 분석 기간 종료시에는 1억 7,870만 달러에 이를 것으로 예측됩니다. 마취제 부문의 성장률은 분석 기간중 CAGR 8.1%로 추정됩니다.

미국 시장은 5,080만 달러로 추정, 중국은 CAGR 13.5%로 성장 예측

미국의 반려동물 수술후 통증 관리 치료제 시장은 2024년에 5,080만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년 CAGR 13.5%로 성장을 지속하여, 2030년에는 예측 시장 규모 6,710만 달러에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 4.3%와 8.3%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.8%로 성장할 전망입니다.

세계의 반려동물 수술후 통증 관리 치료제 시장 - 주요 동향과 촉진요인 정리

수술 후 통증 관리가 수의학에서 중요한 요구가 되고 있는 이유는 무엇일까?

수의학 수술이 고도화됨에 따라 효과적인 수술 후 통증 관리를 보장하는 것은 반려동물 건강관리에서 매우 중요한 요소로 자리 잡았습니다. 정형외과 수술, 종양 제거, 발치 등의 시술을 받는 반려동물의 수가 증가함에 따라 신뢰할 수 있는 진통 솔루션에 대한 수요가 증가하고 있습니다. 불충분한 통증 관리는 회복을 지연시킬 뿐만 아니라 면역 억제, 운동 능력 저하, 반려동물의 행동적 고통과 같은 합병증을 유발할 수 있습니다. 수의사들은 비스테로이드성 항염증제, 오피오이드, 그리고 가바펜티노이드나 국소마취제와 같은 보조 진통제를 조합하여 진통을 최적화하는 멀티모달 진통 접근법을 채택하고 있습니다. 또한, 규제상의 제한과 잠재적인 부작용에 대한 우려로 인해 오피오이드를 사용하지 않는 대체 약물로의 전환이 가속화되고 있습니다. 반려동물 보호자들은 통증 관리의 중요성을 점점 더 인식하고 있으며, 더 안전하고, 더 오래 지속되며, 더 효과적인 치료제에 대한 수요가 증가하고 있습니다. 이에 따라 제약사들은 부작용을 최소화하면서 수술 후 관리를 개선하는 새로운 제제를 개발하기 위해 연구개발에 많은 투자를 하고 있습니다.

동물용 통증 치료제의 기술 혁신은 시장 트렌드를 어떻게 형성하고 있는가?

동물용 통증 치료제의 발전은 반려동물의 수술 후 통증 관리 방식을 바꾸고 있습니다. 가장 주목할 만한 혁신 중 하나는 수술 후 며칠 동안 지속적인 진통 효과를 제공하는 서방형 주사 진통제의 개발입니다. 이러한 제제는 여러 번 투여할 필요성을 줄이고, 치료 순응도를 높이며, 반려동물이 더 편안하게 회복할 수 있도록 돕습니다. 생물학적 제제 및 재생의료 치료의 부상도 시장 성장에 기여하고 있습니다. 혈소판이 풍부한 혈장 및 줄기세포 치료와 같은 치료는 염증을 억제하고 조직 치유를 촉진하는 능력이 있어 장기적인 약물 개입의 필요성을 최소화할 수 있는 것으로 연구되고 있습니다. 또한, 경피 약물 전달 시스템이나 협측 흡수 제제의 사용으로 경구약이나 주사제에 따른 스트레스를 없애고, 통증 관리가 더욱 편리해지고 있습니다. 수의사의 원격의료와 AI를 활용한 통증 평가 도구는 수술 후 통증 관리를 더욱 강화하고 있습니다. 원격 모니터링 솔루션을 통해 수의사는 통증 수준을 평가하고 그에 따라 치료 계획을 조정할 수 있어 적시에 개입할 수 있습니다. 반려동물의 행동과 활력징후를 분석하는 AI 기반 용도는 통증 감지 정확도를 향상시켜 보다 정확한 투약과 전반적인 결과 개선으로 이어집니다.

첨단 통증 완화 솔루션 수요에 영향을 미치는 시장 동향은 무엇인가?

반려동물의 행복과 삶의 질에 대한 관심 증가는 첨단 통증 관리 치료제 수요를 이끄는 가장 중요한 트렌드 중 하나입니다. 오늘날 반려동물 보호자들은 자신과 같은 수준의 건강 관리를 동물에게도 요구하고 있으며, 이에 따라 장기 지속적이고 최소 침습적인 통증 완화 솔루션에 대한 관심이 높아지고 있습니다. 또한, 반려동물 보험의 보급으로 반려동물 보호자들이 고가의 치료를 쉽게 받을 수 있게 되면서 고급 치료제 시장 침투가 가속화되고 있습니다. 시장 역학 형성에는 규제의 발전이 중요한 역할을 하고 있습니다. 오피오이드가 주성분인 의약품의 사용을 둘러싼 가이드라인이 강화됨에 따라 대체 통증 완화 방안에 대한 관심이 높아지고 있습니다. 동물용의약품 업계는 새로운 항염증제, 비오피오이드 진통제, 콜드 레이저 치료 및 침술과 같은 보완요법 개발로 대응하고 있습니다. 또한, 약물 남용과 항생제 내성에 대한 우려가 커지면서 허브 및 CBD 기반 치료제와 같은 전체론적, 식물성 통증 관리 솔루션에 대한 수요가 증가하고 있습니다. 동물병원 및 클리닉은 종합적인 통증 관리 프로그램을 포함한 서비스 제공을 확대하고 있습니다. 많은 시설에서 수술 전 진통, 수술 중 마취 기술, 수술 후 재활 요법을 표준 치료 프로토콜에 통합하고 있습니다. 이러한 통합적 접근 방식은 수술 결과를 개선하고 전문적인 통증 관리 솔루션에 대한 수요를 증가시켜 시장 성장을 더욱 촉진하고 있습니다.

시장 성장의 주요 촉진요인은?

반려동물 수술 후 통증 관리 치료 시장의 성장은 기술 발전, 외과 수술 증가, 소비자 기대치의 진화 등 여러 가지 요인에 의해 이루어지고 있습니다. 주요 요인 중 하나는 반려동물의 정형외과 및 연부조직 수술의 보급률이 증가함에 따라 효과적인 수술 후 통증 완화가 요구되고 있다는 점입니다. 반려동물의 비만율이 증가함에 따라 십자인대 손상 및 골관절염과 같은 질환이 흔해지면서 수술 횟수가 증가하고, 장기적인 통증 관리 솔루션의 필요성이 증가하고 있습니다. 동물용 의약품 산업의 확대도 중요한 성장 요인입니다. 더 많은 기업들이 연구개발에 투자하고 있으며, 동물 종에 특화된 통증 관리 약품의 가용성이 증가하고 있습니다. 이러한 새로운 제제는 다양한 반려동물의 고유한 생리적 반응에 대응하도록 설계되어 보다 안전하고 효과적인 통증 완화를 보장합니다. 또한, 서방형 주사제, 나노기술 기반 제제 등 약물 전달 방법의 혁신을 통해 부작용을 줄이면서 치료 효과를 향상시키고 있습니다.

반려동물 보험과 동물용 웰니스 플랜의 보급 확대도 시장 확대에 큰 역할을 하고 있습니다. 점점 더 많은 보호자들이 수술 및 수술 후 통증 관리를 보장하는 보험을 선택하고 있으며, 첨단 치료제에 대한 접근성이 높아지고 있습니다. 이러한 추세는 특히 북미와 유럽에서 두드러지게 나타나고 있으며, 반려동물 보험의 보급률은 지속적으로 증가하고 있습니다. 대체 및 통합적 통증 관리 전략이 점차 수용되고 있는 것도 시장 성장에 기여하고 있습니다. 레이저 요법, 물리치료, 영양 보충제와 같은 총체적 접근법이 복합적 통증 관리 프로토콜에 통합되고 있습니다. 수의학이 개인 맞춤형 의료와 예방 의료로 전환하는 가운데, 수술 후 통증 관리 치료제의 미래는 첨단 약리학적 솔루션과 보완적 치료법의 조합에 있습니다.

이러한 요인들이 종합적으로 반려동물 수술 후 통증 관리 치료제 시장을 형성하고 있으며, 업계는 지속적인 기술 혁신, 소비자 선호도 변화, 동물용 헬스케어의 발전에 힘입어 지속적인 성장이 예상됩니다.

부문

제품 유형(비스테로이드성 항염증제, 마취제, 오피오이드, 기타 제품 유형), 동물 유형(개, 고양이, 말, 기타 동물 유형), 투여 경로(경구 투여, 주사 투여), 최종사용자(동물 병원 및 진료소 최종사용자, E-Commerce 최종사용자, 소매 최종사용자)

조사 대상 기업 예

  • Aratana Therapeutics
  • Assisi Animal Health
  • Bayer AG
  • Bimeda Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Chanelle Pharma
  • Companion Animal Health
  • Daiichi Sankyo
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Heska Corporation
  • Merck Animal Health
  • Norbrook Laboratories
  • Pegasus Laser Therapy
  • SAVA Vet
  • Vetoquinol
  • Vetoquinol S.A.
  • Virbac
  • Zoetis

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.29

Global Companion Animal Postoperative Pain Management Therapeutics Market to Reach US$306.2 Million by 2030

The global market for Companion Animal Postoperative Pain Management Therapeutics estimated at US$186.6 Million in the year 2024, is expected to reach US$306.2 Million by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. NSAIDs, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$178.7 Million by the end of the analysis period. Growth in the Anesthetics segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$50.8 Million While China is Forecast to Grow at 13.5% CAGR

The Companion Animal Postoperative Pain Management Therapeutics market in the U.S. is estimated at US$50.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$67.1 Million by the year 2030 trailing a CAGR of 13.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Companion Animal Postoperative Pain Management Therapeutics Market - Key Trends & Drivers Summarized

Why Is Postoperative Pain Management Becoming a Critical Need in Veterinary Medicine?

As veterinary surgical procedures become more advanced, ensuring effective postoperative pain management has become a crucial component of companion animal healthcare. With an increasing number of pets undergoing procedures such as orthopedic surgeries, tumor removals, and dental extractions, the demand for reliable pain relief solutions is growing. Inadequate pain management not only prolongs recovery but also leads to complications such as immune suppression, decreased mobility, and behavioral distress in pets. Veterinarians are adopting multimodal analgesia approaches, combining nonsteroidal anti-inflammatory drugs, opioids, and adjunctive analgesics like gabapentinoids and local anesthetics to optimize pain relief. The shift toward opioid-free alternatives is also gaining momentum due to concerns over regulatory restrictions and potential side effects. Pet owners are becoming increasingly aware of the importance of pain management, driving the demand for safer, longer-lasting, and more effective therapeutics. As a result, pharmaceutical companies are investing heavily in research and development to create novel formulations that improve postoperative care while minimizing adverse effects.

How Are Innovations in Veterinary Pain Therapeutics Shaping Market Trends?

Advancements in veterinary pain therapeutics are transforming the way postoperative pain is managed in companion animals. One of the most notable innovations is the development of extended-release injectable analgesics, which provide sustained pain relief for several days after surgery. These formulations reduce the need for multiple doses, improve treatment compliance, and ensure a more comfortable recovery for pets. The rise of biologic and regenerative medicine therapies is also contributing to market growth. Treatments such as platelet-rich plasma and stem cell therapy are being explored for their ability to reduce inflammation and accelerate tissue healing, minimizing the need for prolonged pharmaceutical intervention. Additionally, the use of transdermal drug delivery systems and buccal absorption formulations is making pain management more convenient by eliminating the stress associated with oral or injectable medications. Veterinary telemedicine and AI-powered pain assessment tools are further enhancing postoperative pain management. Remote monitoring solutions allow veterinarians to assess pain levels and adjust treatment plans accordingly, ensuring timely intervention. AI-based applications that analyze pet behavior and vital signs are helping to improve accuracy in pain detection, leading to more precise medication dosing and better overall outcomes.

What Market Trends Are Influencing Demand for Advanced Pain Relief Solutions?

The increasing focus on pet well-being and quality of life is one of the most significant trends driving demand for advanced pain management therapeutics. Pet owners today expect the same level of healthcare for their animals as they do for themselves, leading to heightened interest in long-acting, minimally invasive pain relief solutions. The growing adoption of pet insurance is also making it easier for pet owners to afford premium treatments, thereby increasing the market penetration of advanced therapeutics. Regulatory developments are playing a key role in shaping market dynamics. With stricter guidelines surrounding the use of opioid-based medications, there is a growing emphasis on alternative pain relief strategies. The veterinary pharmaceutical industry is responding with the development of novel anti-inflammatory drugs, non-opioid analgesics, and complementary therapies such as cold laser treatments and acupuncture. Additionally, increasing concerns over medication overuse and antibiotic resistance are driving demand for holistic and plant-based pain management solutions, including herbal formulations and CBD-based therapeutics. Veterinary clinics and hospitals are expanding their service offerings to include comprehensive pain management programs. Many facilities are incorporating preoperative analgesia, intraoperative anesthetic techniques, and postoperative rehabilitation therapies into their standard care protocols. This integrative approach is improving surgical outcomes and increasing demand for specialized pain management solutions, further fueling market growth.

What Are the Key Growth Drivers Fueling the Market?

The growth in the companion animal postoperative pain management therapeutics market is driven by several factors, including technological advancements, increasing surgical procedures, and evolving consumer expectations. One of the primary drivers is the rising prevalence of orthopedic and soft tissue surgeries among companion animals, which necessitates effective postoperative pain relief. As pet obesity rates increase, conditions such as cruciate ligament injuries and osteoarthritis are becoming more common, leading to a higher number of surgical interventions and a greater need for long-term pain management solutions. The expansion of the veterinary pharmaceutical industry is another key growth factor. With more companies investing in research and development, the availability of species-specific pain management drugs is increasing. These new formulations are designed to cater to the unique physiological responses of different companion animals, ensuring safer and more effective pain relief. Additionally, innovations in drug delivery methods, including sustained-release injections and nanotechnology-based formulations, are improving therapeutic efficacy while reducing side effects.

The growing penetration of pet insurance and veterinary wellness plans is also playing a significant role in market expansion. More pet owners are opting for insurance policies that cover surgical procedures and postoperative pain management, making advanced therapeutics more accessible. This trend is particularly prominent in North America and Europe, where pet insurance adoption rates continue to rise. The increasing acceptance of alternative and integrative pain management strategies is further contributing to market growth. Holistic approaches such as laser therapy, physiotherapy, and nutraceutical supplements are being incorporated into multimodal pain management protocols. With veterinary medicine shifting toward personalized and preventive care, the future of postoperative pain management therapeutics lies in a combination of advanced pharmacological solutions and complementary treatment modalities.

With these factors collectively shaping the companion animal postoperative pain management therapeutics market, the industry is poised for continued expansion, driven by ongoing innovation, changing consumer preferences, and advancements in veterinary healthcare.

SCOPE OF STUDY:

The report analyzes the Companion Animal Postoperative Pain Management Therapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (NSAIDs, Anesthetics, Opioids, Other Product Types); Animal Type (Dogs, Cats, Horses, Other Animal Types); Administration Route (Oral Administration, Injectable Administration); End-Use (Veterinary Hospitals and Clinics End-Use, E-Commerce End-Use, Retail End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Aratana Therapeutics
  • Assisi Animal Health
  • Bayer AG
  • Bimeda Animal Health
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Chanelle Pharma
  • Companion Animal Health
  • Daiichi Sankyo
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Heska Corporation
  • Merck Animal Health
  • Norbrook Laboratories
  • Pegasus Laser Therapy
  • SAVA Vet
  • Vetoquinol
  • Vetoquinol S.A.
  • Virbac
  • Zoetis

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Companion Animal Postoperative Pain Management Therapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Adoption of Advanced Surgical Procedures in Companion Animals Drives Post-Op Pain Therapy Demand
    • OEM Development of Long-Acting Analgesics and Local Anesthetics Enhances Recovery Outcomes
    • Growing Emphasis on Multimodal Pain Management Protocols Supports Use of Combination Therapies
    • Veterinarians Prioritizing Pain Scoring and Behavioral Assessment Tools Improve Tailored Treatment
    • Expansion of Opioid-Sparing and Non-Steroidal Pain Medications Reduces Side Effects and Owner Concerns
    • OEMs Offering Rapid-Onset and Extended-Release Formulations Support In-Hospital and At-Home Use
    • Growing Demand for Pain Management in Orthopedic, Dental, and Soft Tissue Surgeries Boosts Market
    • Integration of Pain Management Modules in Veterinary Software Enhances Documentation and Compliance
    • OEMs Developing Palatable and Easy-to-Administer Products Improve Owner Adherence
    • Rising Availability of Pain Management Add-Ons in Wellness Plans Encourages Proactive Care
    • Veterinary Education Programs Emphasizing Pain Control Improve Uptake in General Practices
    • OEMs Collaborating With Anesthesia Equipment Providers Offer Bundled Surgery-Pain Management Solutions
    • Growing Use of Nerve Blocks and Regional Anesthesia Techniques Expands Pain Management Modalities
    • Veterinary Hospitals Standardizing Recovery Protocols Drive Product Consistency and Market Growth
    • Increased Awareness of Animal Pain Expression Enhances Diagnostic Accuracy and Treatment Initiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Companion Animal Postoperative Pain Management Therapeutics Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Opioids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Injectable Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Veterinary Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Veterinary Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for E-Commerce End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for E-Commerce End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for E-Commerce End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Retail End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Retail End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Retail End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Dogs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Cats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Horses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Horses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Horses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • CHINA
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 80: China Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 143: UK Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • INDIA
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 218: India Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: India Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Companion Animal Postoperative Pain Management Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Product Type - NSAIDs, Anesthetics, Opioids and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Product Type - Percentage Breakdown of Value Sales for NSAIDs, Anesthetics, Opioids and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Injectable Administration and Oral Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Injectable Administration and Oral Administration for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics End-Use, E-Commerce End-Use and Retail End-Use for the Years 2015, 2025 & 2030
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Dogs, Cats, Horses and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Companion Animal Postoperative Pain Management Therapeutics by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats, Horses and Other Animal Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제